Subject(s)
Humans , Female , Male , Thoracic Surgery , Heart Valve Prosthesis Implantation , Heart Valve Prosthesis , Cardiac Catheterization , EchocardiographyABSTRACT
47 patients aged from 2 to 59 years affected by valvular congenital or mixed pulmonary stenosis including three fallot trilogies and one patient with right congestive cardiac failure are treated by percutaneous pulmonary valvulotomy between October 1986 and December 1990. All patients have been controlled with a mean follow-up of 6.5 +/- 1.1 years. The total gradient rate between pulmonary artery and right ventricule decrease from 112 +/- 55 mm Hg to 20 +/- 8 mm Hg on the last control with disappearance of infundibular inflammation and their auricular shunt in all the concerned cases. We observe the degression of right cardiac failure symptoms with disappearance of tricuspid insufficiency in the cases of advanced pulmonary stenosis with right ventricular dysfunction. Percutaneous pulmonary valvulotomie by its simplicity and inocuity, its long term efficiency is a good method of treatment of pure valvular or mixed pulmonary stenosis
Subject(s)
Humans , Male , Female , Cardiac Catheterization , Heart Defects, Congenital , Trilogy of FallotABSTRACT
We report a new simplified method of mitral dilatation done on 146 patients. The technique use the lnoue balloon with progressive diameters under ultrasonographic control, avoiding the arterial part of the dilatation. The population include 9 pregnant women, 13 children, 13 with restenosis and closed heart and 12 restenosis after dilatation. Mean age is 32 +/- 16 years [9 to 72] and sex ratio 3.7 [114 F/32 M]. Three groups are individualized according to histopathologic exam of metal struclure, group [26 percent] concern good indication and III [32 percent] bad indication for this technique, group II [42 percent] contain intermediate indications. Commissurolomy increase the mean mitral square for 0.2 to 1.9 +/- cm'. We observe 3 cases of chirurgical mitral insufficiency needing remplacement recuited for 2 patients from the group III. Mean fluoroscopic exposition time is 5.2 +/- 3.3 mn and procedure duration 18 +/- 11 mn. Hospitalisation duration is one day for 95 percent of the patients. This method remaining simple, efficient and safe permit a gain in time of 70 percent with a good confort for patient and a return to work on the 4th day